vida: research 2026 04 28 #4496

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 07:46:44 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 07:47 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 07:47 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal entry synthesizes information, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes to support the "significantly strengthened" assessment.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company actions (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal entry synthesizes information, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes to support the "significantly strengthened" assessment. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR adds a new research journal session (2026-04-28) and associated source files; no enrichments to existing claims are present, so no duplicate evidence injection is possible.

3. Confidence:
No claims are being modified or created in this PR, only research journal entries and source files, so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual broken links detected in the diff.

5. Source quality:
The research journal cites specific commercial outcomes (WeightWatchers Chapter 11 bankruptcy May 2025, Omada Health IPO June 2025, Noom biomarker testing December 2025, manufacturer DTE launches) with concrete metrics that are verifiable against the source files being added to inbox/queue/.

6. Specificity:
No claims are being created or modified in this PR — only research journal entries and source files — so specificity evaluation of claim titles does not apply.

Overall assessment:
This PR adds research documentation and source files without modifying any claims or entities; the research journal entry documents a disconfirmation attempt of "Belief 4" with specific commercial outcomes (bankruptcy vs. profitable IPO) that provide falsifiable evidence, and the associated source files in inbox/queue/ support the analysis with concrete market data.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR adds a new research journal session (2026-04-28) and associated source files; no enrichments to existing claims are present, so no duplicate evidence injection is possible. **3. Confidence:** No claims are being modified or created in this PR, only research journal entries and source files, so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and "Belief 1" without [[wiki links]], but these appear to be internal research framework references rather than broken links to KB claims; no actual [[broken links]] detected in the diff. **5. Source quality:** The research journal cites specific commercial outcomes (WeightWatchers Chapter 11 bankruptcy May 2025, Omada Health IPO June 2025, Noom biomarker testing December 2025, manufacturer DTE launches) with concrete metrics that are verifiable against the source files being added to inbox/queue/. **6. Specificity:** No claims are being created or modified in this PR — only research journal entries and source files — so specificity evaluation of claim titles does not apply. **Overall assessment:** This PR adds research documentation and source files without modifying any claims or entities; the research journal entry documents a disconfirmation attempt of "Belief 4" with specific commercial outcomes (bankruptcy vs. profitable IPO) that provide falsifiable evidence, and the associated source files in inbox/queue/ support the analysis with concrete market data. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 07:48:52 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 07:48:52 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 07:50:55 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.